Ignite Creation Date:
2024-05-06 @ 1:08 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03946358
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-26
First Post:
2019-05-07
Brief Title:
Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers VolATIL
Sponsor:
Centre Hospitalier Universitaire de Besancon
Organization:
Centre Hospitalier Universitaire de Besancon
Organization Data
Organization:
Centre Hospitalier Universitaire de Besancon
Class:
OTHER
Study ID:
P2019418
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute France | OTHER_GOV |
| Roche Pharma AG | INDUSTRY |